INIS
cancer
100%
prostate
72%
spores
45%
therapy
27%
applications
27%
androgens
18%
animals
18%
universities
18%
clinical trials
18%
amp
13%
ablation
9%
modulation
9%
leptin
9%
epidemiology
9%
reductases
9%
diseases
9%
chicago
9%
procurement
9%
advisory committees
9%
patients
9%
management
9%
populations
9%
reviews
9%
radiations
9%
regulations
9%
environment
9%
inhibition
9%
Medicine and Dentistry
Prostate Cancer
72%
Clinical Trial
27%
Translational Research
18%
Cancer Research
18%
Androgen
18%
Combination Therapy
18%
Animal Study
18%
Radiation
13%
Leadership
9%
Epigenomics
9%
Ablation Therapy
9%
Steroid 5alpha Reductase
9%
Biostatistics
9%
Specimen
9%
Cell Motility
9%
Adipogenesis
9%
Cancer Cell
9%
Pigment Epithelium Derived Factor
9%
Diseases
9%
Tumor Necrosis Factor
9%
Genistein
9%
Leptin
9%
Advanced Cancer
9%
Patient Population
9%
Development
9%
Regulatory Mechanism
9%
Malignant Neoplasm
9%
Molecular Epidemiology
9%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
36%
Androgen
9%